Centre Hospitalier Universitaire d'Angers

Angers, Maine-et-Loire 49933

1 studies enrolling now · 5 studies all time

What they study most

Adjuvant, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Diabetes Mellitus, Type 2, EGFR, Early Stage Lung Cancer, Endocrine System Diseases, Exon 20, Glucose Metabolism Disorders, Lung Cancer, Medullary Thyroid Cancer, Metabolic Disease

Studies at this site

• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) — Recruiting now
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling
• A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed